Comprehensive resources for HIV microbicides and biomedical prevention
Ended Awarded Last action
- Contract number
- HHSN27200011
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $313,653
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 10% obligated
-
- $313,652.64 Current, with exercised options
- $3,150,428.64 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$292,743 | |
| Funding Only Action | -$194,646 | |
| Exercise an Option | $406,921 | |
| Original award | $394,121 |
About this award
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The $3,150,428.64 award is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL will provide comprehensive resources for HIV microbicides and biomedical prevention, including biologics manufacturing, testing, storage, shipping, and quality assurance services. This work supports preclinical and clinical development of vaccine candidates, monoclonal antibodies, adjuvants, and other biologics. The contract does not have a set-aside designation and is a cost-plus-fixed-fee arrangement with a period of performance through August 31, 2023.
Quick answers
Who was awarded contract HHSN27200011?
HHSN27200011 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 24, 2017.
How much is contract HHSN27200011 worth?
The government has obligated $313,653 on HHSN27200011. Its potential value, with all options, is $3,150,429.
Is contract HHSN27200011 an order under another contract?
Yes. HHSN27200011 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract HHSN27200011 competed?
The extent of competition for HHSN27200011 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award